Asthma Tied to Later Inflammatory Bowel Disease

This article originally appeared here.
Share this content:
Asthma Tied to Later Inflammatory Bowel Disease
Asthma Tied to Later Inflammatory Bowel Disease

FRIDAY, Aug. 25, 2017 (HealthDay News) -- Asthma is associated with subsequent development of inflammatory bowel disease (IBD), according to a study published in the September issue of Clinical Gastroenterology and Hepatology.

M. Ellen Kuenzig, Ph.D., from University of Calgary in Canada, and colleagues used health administrative data to examine the association between a diagnosis of asthma and Crohn's disease (3,087 patients) or ulcerative colitis (2,377 patients) compared to a diagnosis of asthma among persons without IBD (402,800 patients).

The researchers found that a diagnosis of asthma was associated with increased odds of incident Crohn's disease (adjusted odds ratio [OR], 1.45; 95 percent confidence interval [CI], 1.31 to 1.60). Age at diagnosis did not change the effect for Crohn's disease (P > 0.42). However, age at diagnosis did modify the effect for ulcerative colitis (P = 0.0103), with an adjusted OR of 1.49 (95 percent CI, 1.08 to 2.07) for individuals diagnosed at ≤16 years and an adjusted OR of 1.57 (95 percent CI, 1.31 to 1.89) among individuals diagnosed at >40 years. Among individuals diagnosed between ages 17 and 40 years, there was no association between asthma and ulcerative colitis (adjusted OR, 1.05; 95 percent CI, 0.86 to 1.26).

"In a population-based case-control study, we associated asthma with Crohn's disease, and with early- and late-onset ulcerative colitis," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »